Title Credit Category Series datesort descending Cost
Hypofractionation for Soft Tissue Sarcoma
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Certificate of Attendance
Sessions onDemand 12/03/2024 to 12/02/2026 $149.00
Gray Zone - Put Your Best Smile Forward: Rhabdomyosarcoma of the Parotid Gland
    • 1.00 AMA PRA Category 1 Credit™
Journal Activities 12/12/2024 to 12/11/2025 $0.00
Mechanistic Insights and Knowledge Gaps in the Effects of Radiation Therapy on Cardiac Arrhythmias
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Certificate of Attendance
Journal Activities 12/12/2024 to 12/11/2026 $49.00
Relevant or Relegated? Radiotherapy for Stage III NSCLC in the Neoadjuvant Era
    • 1.25 AMA PRA Category 1 Credit™
    • 1.25 Certificate of Attendance
12/17/2024 to 12/16/2026 $0.00
Beyond Counting on Our Fingers: The Current State and Future Management of Oligometastatic Lung Cancer
    • 1.25 AMA PRA Category 1 Credit™
    • 1.25 Certificate of Attendance
Sessions onDemand 12/17/2024 to 12/16/2026 $149.00
2025 Quarter 1 - Journal Reviewer CME
    • 3.00 AMA PRA Category 1 Credit™
Journal Activities 01/01/2025 to 04/30/2025 $0.00
Challenging Cases in Palliative Care: Novel Therapeutics, Radioresistant Histology and Treatment Delivery
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Certificate of Attendance
01/03/2025 to 01/02/2027 $149.00
Challenging Cases in the Management of Squamous Cell Carcinoma of the Skin
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Certificate of Attendance
01/03/2025 to 01/02/2027 $149.00
Survival (Time-To-Event) Curve Names and Endpoints
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Certificate of Attendance
Journal Activities 01/06/2025 to 01/05/2027 $49.00
Is Consolidation Radiotherapy Still Needed for Lymphoma in 2024? Reappraisal in Light of Recent Trials Results
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Certificate of Attendance
Sessions onDemand 01/07/2025 to 01/06/2027 $149.00
At the Cutting Edge: The Increasing Role of Salvage Radiotherapy in Relapsed/Refractory Lymphomas
    • 1.25 AMA PRA Category 1 Credit™
    • 1.25 Certificate of Attendance
Sessions onDemand 01/07/2025 to 01/06/2027 $149.00
Evolving Paradigms in Prostate Cancer: The Integral Role of PSMA PET/CT in Primary Staging and Therapeutic Decision-Making
    • 1.00 AMA PRA Category 1 Credit™
Journal Activities 01/13/2025 to 01/12/2027 $49.00
ASTRO-AstraZeneca SCLC Therapy Challenge Kick-Off
    • 0.00 Certificate of Attendance
onDemand, Webinars 01/13/2025 to 05/15/2025 $0.00
Gray Zone - Tip of the Iceberg or the Whole Titanic: Discrepant Representation of Glioblastoma on Different Imaging Modalities
    • 1.00 AMA PRA Category 1 Credit™
Journal Activities 01/13/2025 to 01/12/2026 $0.00
Practical Elements of a Radiopharmaceutical Program: Findings from ASTRO's Safety White Paper
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Certificate of Attendance
Sessions onDemand 01/14/2025 to 01/13/2027 $149.00

Pages